Show simple item record

dc.date.accessioned2020-04-01T20:33:46Z
dc.date.available2020-04-01T20:33:46Z
dc.date.issued2020-03-17
dc.identifier.urihttps://clinicaltrials.gov/ct2/show/NCT04292964en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/897
dc.description.abstractThe outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19.en_US
dc.languageEnglishen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectSARS Virusen_US
dc.subjectSevere Acute Respiratory Syndromeen_US
dc.subjectPrognosisen_US
dc.subjectClinical Trialen_US
dc.titlePrognostic Factors of Patients With COVID-19en_US
eihealth.countryOthersen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typeResearch protocol informationen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalClinicalTrials.goven_US
dc.contributor.corporatenameChongqing Medical University


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record